ImageneBio Inc(IMA)

$6.07—Earnings · Jul 23

Chart

ImageneBio Inc(IMA)

NASDAQ

$6.07—Earnings · Jul 23

Chart Studio

IMA(IMA)

IMA

Overview Notebook Intelligence Chart History Fundmntls TTM Earnings Analysts News Financials Segments Insiders Institl.DCF Peers

Q3 2026 EPS Estimate

$-0.98

Jul 23, 2026 · Reports before open

Analyst Sentiment

Wall St. Consensus

Buy

5 analysts·Limited coverage

Score

4 Buy (80%)0 Hold (0%)1 Sell (20%)

Rating Breakdown

Strong Buy

00%

Buy

480%

Hold

00%

Sell

120%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear

$1.33

-78.1%

Consensus

$1.33

-78.1%

Bull

$1.33

-78.1%

12-Month Target Range5 analysts

$1.33$1.33$1.33

Current $6.07Consensus

Current Price

$6.07

Above Consensus

$4.74

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev-57.47%

EPS—

FY2028

Rev-57.47%

EPS—

FY2029

Rev-57.47%

EPS—

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2026E	FY2027E	FY2028E	FY2029E	FY2030E
Revenue Avg	$340,244	$144,707	$61,544	$26,175	$21M
Low	$340,244	$144,707	$61,544	$26,175	$21M
High	$340,244	$144,707	$61,544	$26,175	$21M
EBITDA Avg	$-340,244	$-144,707	$-61,544	$-26,175	$-21M
Low	$-340,244	$-144,707	$-61,544	$-26,175	$-21M
High	$-340,244	$-144,707	$-61,544	$-26,175	$-21M
EBIT Avg	$-340,244	$-144,707	$-61,544	$-26,175	$-21M
Low	$-340,244	$-144,707	$-61,544	$-26,175	$-21M
High	$-340,244	$-144,707	$-61,544	$-26,175	$-21M
Net Income Avg	$-20M	$-15M	$-16M	$-17M	$-19M
Low	$-20M	$-22M	$-27M	$-17M	$-19M
High	$-19M	$-8M	$-5M	$-17M	$-19M
EPS Avg	$-4.10	$-3.07	$-3.95	$-3.57	$-3.88
Low	$-4.20	$-4.59	$-5.48	$-3.57	$-3.88
High	$-3.99	$-1.54	$-1.01	$-3.57	$-3.88
Analysts (Rev / EPS)	3 / 2	3 / 2	3 / 3	2 / 1	1 / 1

Quarterly

Metric	Q3 2026	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027	Q1 2028	Q2 2028
Revenue Avg	—	—	—	—	—	—	—	—
Low	—	—	—	—	—	—	—	—
High	—	—	—	—	—	—	—	—
EBITDA Avg	—	—	—	—	—	—	—	—
Low	—	—	—	—	—	—	—	—
High	—	—	—	—	—	—	—	—
EBIT Avg	—	—	—	—	—	—	—	—
Low	—	—	—	—	—	—	—	—
High	—	—	—	—	—	—	—	—
Net Income Avg	$-12M	$-13M	$-11M	$-11M	$-12M	$-15M	$-6M	$-6M
Low	$-12M	$-13M	$-11M	$-11M	$-12M	$-15M	$-6M	$-6M
High	$-12M	$-13M	$-11M	$-11M	$-12M	$-15M	$-6M	$-6M
EPS Avg	$-1.10	$-1.19	$-1.02	$-0.94	$-1.06	$-1.37	$-0.55	$-0.57
Low	$-1.10	$-1.19	$-1.02	$-0.94	$-1.06	$-1.37	$-0.55	$-0.57
High	$-1.09	$-1.19	$-1.02	$-0.94	$-1.06	$-1.37	$-0.55	$-0.57
Analysts (Rev / EPS)	— / 2	— / 1	— / 1	— / 1	— / 1	— / 1	— / 1	— / 1

Earnings Surprises

Recent Analyst Actions

May 29, 2024Wedbush

This American Airlines Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Target:$1.33

-18.9%from $1.64

May 29, 2024Wedbush

iKena Oncology downgraded to Neutral from Outperform at Wedbush

Target:$2.00

+50.4%from $1.33

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance